Harel, W <br/><br/>
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.  [electronic resource] 

 -  Cancer research  Oct 1990 
 - 6311-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibody Specificity<br/>Antibody-Dependent Cell Cytotoxicity--immunology<br/>Antigens, Neoplasm<br/>Antigens, Surface--immunology<br/>Gangliosides--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Melanoma--immunology<br/>Melanoma-Specific Antigens<br/>Neoplasm Proteins--immunology<br/>Tumor Cells, Cultured